Oral Cysts, Tumours & Pathology: How Oral Surgeons Diagnose and Remove Jaw Lesions product guide

Smile Solutions: Oral Cysts, Tumours & Pathology – How Oral Surgeons Diagnose and Remove Jaw Lesions

When you visit an oral surgeon, you're probably thinking about wisdom teeth, dental implants, or corrective jaw surgery. But one of the most clinically significant — and least publicly discussed — areas of oral and maxillofacial surgery is the diagnosis and management of pathological lesions within the jaw bones themselves: cysts, benign tumours, and, in some cases, malignancies that grow silently inside the mandible or maxilla for months or years before causing any symptoms. At Smile Solutions, Melbourne's multidisciplinary dental and oral surgery practice, this kind of specialist care is something our oral and maxillofacial surgery team handles every day.

These are not rare curiosities. Jaw cysts are a diverse group of intraosseous lesions commonly encountered in oral and maxillofacial pathology, and several studies have addressed their distribution and clinicopathological features. A landmark retrospective study published in BMC Oral Health (Kokubun et al., 2026) reviewed 19,352 histologically confirmed jaw cysts diagnosed over an almost 50-year period, evaluating demographic and anatomical characteristics across cyst categories. The clinical stakes are real: untreated jaw lesions can silently destroy bone, displace teeth, damage nerves, and — in a small but critical subset of cases — undergo malignant transformation.

This article explains what these lesions are, how an oral and maxillofacial surgeon identifies them, and what surgical options exist, from the most conservative through to the most complex. If you've been referred for an unexplained jaw radiolucency, an incidental finding on a panoramic X-ray, or a swelling your general dentist can't explain, understanding this area of the specialty matters enormously.

What are jaw cysts and odontogenic tumours?

The odontogenic origin

Odontogenic cysts of the jaws arise from epithelial remnants of the epithelial-mesenchymal interactions that underpin normal tooth development. The pathogenesis varies for each type of cyst, but they are broadly grouped as inflammatory or developmental in nature.

In plain terms: the same biological machinery that builds your teeth leaves behind microscopic cellular remnants throughout your jaw. Under the right conditions — infection, developmental anomaly, or genetic predisposition — these remnants can proliferate into cysts or tumours. Benign tumours are classified into three major categories according to their histogenetic origin: epithelial, mesenchymal, and mixed types.

How common are they?

A large epidemiological study published in Oral Diseases (Rees et al., 2024–2025), reviewing 22,914 biopsy requests over nearly four decades, found that 4,226 (18.4%) were cysts and 551 (2.4%) were odontogenic tumours, in patients ranging from 2 to 97 years old. The distribution by type is clinically important: the most prevalent cysts were radicular cysts (58.6%), dentigerous cysts (17.9%), and odontogenic keratocysts (13.3%). The most prevalent odontogenic tumours were odontomas (40.1%) and conventional ameloblastoma (17.6%).

Incidence of odontogenic tumours also varies significantly by geography. Whilst they represent 1% of all oral pathologies in some developed nations, this figure has been reported as high as 19% in African nations.

The three lesions every patient should know

1. Dentigerous cysts

The dentigerous cyst is the second most common jaw cyst and is closely linked to impacted teeth — most commonly impacted wisdom teeth (see our guide on Impacted Wisdom Teeth: Causes, Symptoms & Why an Oral Surgeon Should Remove Them). It usually presents as a unilocular translucent lesion that causes minimal discomfort alongside bony expansion around the impacted third molar.

The cyst forms when fluid accumulates between the crown of an unerupted tooth and its surrounding dental follicle. Most dentigerous cysts are benign and manageable with straightforward enucleation, but they carry an underappreciated risk if left untreated. More serious lesions can arise within the cyst walls, including mucoepidermoid carcinoma arising from mucous cells, ameloblastoma (17% of ameloblastomas arise within a dentigerous cyst), and squamous cell carcinoma. Dentigerous cysts can also grow quite large and place you at risk for pathologic jaw fracture.

This is precisely why routine panoramic radiography during wisdom tooth assessment is not merely a preoperative formality — it's a pathology screen, and one your treating specialist takes seriously.

2. Odontogenic keratocysts (OKC)

The odontogenic keratocyst is arguably the most clinically dangerous of the common jaw cysts. It is a rare but locally aggressive developmental cyst that most often affects the posterior mandible and typically presents in the third decade of life.

What makes the OKC particularly treacherous is its growth pattern. Early odontogenic keratocysts usually produce no symptoms. Clinical signs — bony expansion or infection — tend to appear later, if at all. Bony expansion is actually uncommon, because odontogenic keratocysts grow via increased epithelial turnover rather than osmotic pressure. This means a large OKC can expand extensively along the medullary cavity of your jaw with minimal external swelling, making it invisible to clinical examination and detectable only on imaging.

The genetic basis of OKC is also clinically significant. Sporadic and syndromic OKCs are associated with mutations in the PTCH gene on chromosome 9q, which is part of the Hedgehog signalling pathway. PTCH is a tumour suppressor gene, and loss of its activity disrupts normal cell cycle regulation. Approximately one third of OKCs show PTCH mutations, causing the cyst epithelium to undergo highly proliferative activity.

Critically, multiple odontogenic keratocysts are a feature — and a major diagnostic criterion — of nevoid basal cell carcinoma syndrome (NBCCS, also known as Gorlin-Goltz Syndrome). Almost all individuals with NBCCS develop odontogenic keratocysts requiring numerous treatments. If multiple OKCs are found in a child, referral for genetic evaluation is necessary.

3. Ameloblastoma

Ameloblastoma is the second most common odontogenic tumour after odontoma. It can originate from remnants of the dental lamina, the enamel organ, odontogenic cyst lining, or oral mucosa basal cells, and can be either central (intraosseous) or peripheral (extraosseous). It typically presents as a slow-growing, minimally uncomfortable swelling that may lead to cortical bone bulging, malocclusion, tooth loosening, and potentially significant facial deformity.

Despite being classified as benign, ameloblastoma's behaviour is anything but straightforward. It is locally aggressive and carries a high recurrence rate — a combination that makes surgical decision-making in these cases among the most consequential in the specialty.

How jaw lesions are diagnosed: the imaging and biopsy pathway

Step 1: Panoramic radiography (OPG) as the first screen

The orthopantomogram (OPG) is the entry-level imaging tool for most jaw lesions. It provides a broad survey of both jaws, the temporomandibular joints, and the full dentition in a single exposure. Most jaw cysts and tumours are first detected incidentally on an OPG taken for another purpose — wisdom tooth assessment or a routine dental review.

The differential diagnosis of jaw lesions spans cystic, neoplastic, and vascular anomalies, and proper clinical assessment alongside radiographic and histological evaluation is the standard approach to distinguishing between them. A well-defined unilocular appearance is more suggestive of a cystic lesion.

The OPG has real limitations, though. It cannot reliably distinguish between a dentigerous cyst, an OKC, and a unicystic ameloblastoma — three lesions that can appear radiographically identical yet require dramatically different surgical treatment. This is where the expertise of a board-registered specialist becomes essential.

Step 2: CBCT and CT for three-dimensional assessment

Radiographic examination of any hard tissue lesion is recommended to evaluate size and guide procedural planning. An initial office-based OPG or cone-beam computed tomography (CBCT) is generally sufficient, with non-contrast medical-grade CT playing a role in evaluating more extensive or invasive lesions.

CBCT has become particularly valuable in oral and maxillofacial pathology. Its usefulness in detecting osteolysis has been confirmed, with sensitivity of 89–93% and specificity of 60–96.5%. It is more accurate than panoramic radiography and comparable to MRI, CT, and bone scintigraphy. Its limitation is poor soft tissue assessment, which is where MRI becomes essential. MRI enables detection of very small lesions, assessment of local tumour spread, surgical planning, and evaluation of complications.

For suspected malignancy, imaging accuracy matters even more. A study in the American Journal of Roentgenology found that CT correctly identified 25 of 26 cases with mandibular invasion by squamous cell carcinoma, and correctly excluded invasion in 20 of 23 cases without it — a sensitivity of 96% and specificity of 87%.

Step 3: Biopsy — the only definitive diagnosis

Imaging can characterise a lesion; only histopathology can diagnose it. Clinical and radiographic findings of jaw lesions often produce a differential diagnosis that only histologic examination will resolve. A dentigerous cyst, an odontogenic keratocyst, and certain ameloblastomas with cystic change can appear radiographically identical — and yet their histologic differences determine treatments that are worlds apart.

The biopsy approach depends on clinical suspicion. An incisional biopsy is recommended when malignancy is suspected, because further surgical intervention will almost certainly follow. If an excisional biopsy of a lesion suspicious for oral squamous cell carcinoma removes the lesion entirely, the consulting oncologist won't know exactly where it was — and that gap in information can adversely affect treatment decisions.

For large lesions where decompression is planned before definitive surgery, the surgical team typically performs an incisional biopsy during stent placement. This step is essential: the biopsy may reveal an unexpected entity — odontogenic or otherwise — that isn't suitable for decompression at all.

Surgical management: from enucleation to jaw resection

The treatment of jaw lesions spans a wide range of surgical complexity. The right choice depends on lesion type, size, location, relationship to vital structures, and histopathological diagnosis — all of which your specialist will assess carefully before recommending a treatment plan.

Comparative overview of surgical approaches

Enucleation and curettage

Most cysts are treated with simple enucleation, with decompression and marsupialization reserved for larger cysts where conventional treatment risks pathological jaw fracture or damage to closely related anatomical structures.

Enucleation — complete removal of a cyst lining from surrounding bone — is appropriate for most radicular and dentigerous cysts. For OKCs, however, simple enucleation carries a meaningful recurrence risk, because the PTCH mutations driving epithelial proliferation mean incomplete removal of epithelium strongly favours recurrence. Adjunct treatments — Carnoy's solution (a chemical cauterant applied to the bony cavity) or peripheral ostectomy — are typically added to reduce this risk.

Marsupialization and decompression

For very large cysts approaching the inferior alveolar nerve or risking pathological fracture, marsupialization — creating a surgical window that allows the cyst to drain and shrink over time — may precede definitive enucleation. This staged approach reduces the volume of bone that must be sacrificed and allows critical structures to move away from the surgical field, making the definitive procedure safer.

Resection for ameloblastoma

The surgical management of ameloblastoma is one of the most debated areas in oral and maxillofacial surgery. The evidence strongly favours radical resection for the conventional solid/multicystic subtype. Recurrence rates reach 15–25% after radical treatment and 55–90% after conservative treatment.

A network meta-analysis published in Scientific Reports (2023) found that segmental resection ranked highest for reducing recurrence, with the highest SUCRA score (77.7), followed by curettage with cryotherapy (66.9) and marginal resection (49.3).

Conservative approaches — enucleation and curettage — are consistently associated with substantially higher recurrence risk, largely because ameloblastomas are infiltrative and often microscopically more extensive than they appear. Recurrence rates after conservative treatment can exceed 50%, particularly in multilocular, follicular, and solid/multicystic variants.

When the tumour is aggressive or combined conservative treatment isn't viable, radical surgery with 0.5–1 cm margins is advised, with reconstruction. For solid and multicystic ameloblastoma specifically, most authors recommend radical surgery with 1 cm margins, resection of adjacent soft tissue, and subsequent reconstruction.

One further point worth emphasising: ameloblastoma recurrences can appear up to 10–15 years after treatment. Long-term radiographic surveillance is non-negotiable regardless of the surgical approach chosen, and your specialist will establish a structured follow-up programme tailored to your situation.

Jaw reconstruction after resection

When segmental resection is required, reconstruction is planned concurrently (see our guide on Facial Trauma & Jaw Reconstruction: How Oral & Maxillofacial Surgeons Restore Form and Function). The free fibula flap — a segment of fibula bone from the lower leg, transferred along with its vascular supply to reconstruct the mandible — is the current gold standard for mandibular reconstruction after oncological or pathological resection. Dental implants can subsequently be placed into the reconstructed bone to restore oral function (see our guide on Bone Grafting for Dental Implants: Types, Procedure & How Jaw Bone Loss Is Reversed).

Malignant jaw lesions: when the stakes are highest

Whilst the majority of jaw lesions are benign, our oral and maxillofacial surgeons maintain vigilant clinical awareness for malignancy in every case they assess. In rare instances, malignant disease of the jaws can present clinically and radiologically as an odontogenic cyst.

Oral squamous cell carcinoma (OSCC) is the most common cancer of the oral cavity, constituting 95% of all cancers in this area. Advanced tumours can invade the underlying jaw bone, creating radiographic appearances that mimic benign jaw lesions. Squamous cell carcinomas typically manifest as multilocular or unilocular solid lesions with significant bone destruction and invasion of surrounding tissues.

The diagnostic red flags that should prompt urgent specialist review include:

• A non-healing ulcer or mucosal lesion persisting beyond three weeks
• A jaw radiolucency with irregular or poorly defined margins
• Unexplained tooth mobility not explained by periodontal disease
• Persistent numbness of the lip or chin — a potential sign of inferior alveolar nerve involvement
• Rapid growth of any jaw swelling

The low detection rate of early oral squamous cell carcinoma is a genuine clinical problem. Despite the oral cavity being easily examined, most oral SCC cases are diagnosed at a late stage.

If any of these warning signs apply to you, don't wait. Prompt specialist assessment can make an enormous difference to your outcome.

Why jaw pathology requires a board-registered oral and maxillofacial surgeon

The diagnosis and management of jaw lesions is not a domain for generalist practice. The critical diagnostic decision — distinguishing a simple dentigerous cyst from an OKC or unicystic ameloblastoma on imaging — directly determines whether you undergo a straightforward enucleation or a jaw resection with free-flap reconstruction. Depending on the histologic diagnosis, you may require no further treatment beyond simple enucleation (dentigerous cyst), secondary surgical treatment with mandatory long-term radiographic follow-up (odontogenic keratocyst or unicystic ameloblastoma), or major jaw resection (ameloblastoma).

This level of clinical decision-making requires surgical skill, radiological interpretation, histopathological understanding, and reconstructive capability — the combination that defines the scope of a board-registered oral and maxillofacial surgeon (see our guide on Why Choose a Board-Registered Oral & Maxillofacial Surgeon Over a General Dentist for Complex Procedures).

At Smile Solutions Melbourne, our oral and maxillofacial surgeons work within a genuinely multidisciplinary environment that allows the full diagnostic and surgical pathway — from initial imaging and biopsy through to reconstruction and implant-based rehabilitation — to be coordinated under one roof. That means greater continuity of care, clearer communication, and a more personalised treatment experience at every stage.

Key takeaways

• The most prevalent jaw cysts are radicular cysts (58.6%), dentigerous cysts (17.9%), and odontogenic keratocysts (13.3%) — all of which require histopathological confirmation to distinguish from one another and from tumours.
• The odontogenic keratocyst is a rare but locally aggressive developmental cyst with a high recurrence rate driven by PTCH gene mutations; multiple OKCs are a diagnostic criterion for Gorlin-Goltz Syndrome.
• Ameloblastoma carries recurrence rates of 15–25% after radical treatment and 55–90% after conservative treatment, making the surgical approach decision one of the most consequential in oral oncology.
• Imaging alone is never sufficient for definitive diagnosis — clinical and radiographic findings typically produce a differential that only histologic examination will resolve.
• Malignant jaw lesions can mimic benign cysts on imaging; persistent unexplained jaw lesions, non-healing ulcers, or new-onset lip numbness require urgent specialist review.

Conclusion

Oral and maxillofacial pathology occupies a unique clinical space: lesions invisible to the naked eye, growing silently within bone, ranging from a simple cyst requiring a single surgical visit to an aggressive tumour demanding jaw resection and free-flap reconstruction. The difference between these outcomes comes down to early detection, accurate imaging, definitive histopathological diagnosis, and the surgical expertise to match treatment to diagnosis.

If you're in Melbourne and you've received an unexplained jaw radiolucency finding, or your general dentist has referred you for further investigation, prompt assessment by a board-registered oral and maxillofacial surgeon is the right next step. Whether your finding proves to be a straightforward dentigerous cyst associated with an impacted wisdom tooth, an aggressive OKC requiring careful long-term surveillance, or something requiring more extensive management, the pathway is the same: specialist-led, imaging-guided, and histopathology-confirmed. Our team is here to guide you through every stage.

To understand the full scope of what oral and maxillofacial surgeons treat, read our foundational guide: What Is Oral & Maxillofacial Surgery? Scope, Training & Specialist Qualifications Explained. For patients facing bone loss after tooth extraction or tumour resection, see Bone Grafting for Dental Implants: Types, Procedure & How Jaw Bone Loss Is Reversed.

Smile Solutions has been providing oral and maxillofacial surgery care from Melbourne's CBD since 1993. Located at the Manchester Unity Building, Level 12 and Tower, 220 Collins Street, Smile Solutions brings together 60+ clinicians — including 25+ board-registered specialists — who have cared for over 250,000 patients. No referral is required to book a specialist appointment. Call 13 13 96 or visit smilesolutions.com.au to arrange your oral surgery consultation today.

References

• Kokubun, K., Akashi, Y., Nakajima, K. et al. "Epidemiologic and Clinicopathologic Features of 19,352 Jaw Cysts: A Single-Center Retrospective Study." BMC Oral Health, 2026. https://doi.org/10.1186/s12903-026-07776-y

• Rees, [et al.]. "Epidemiological Features of 4777 Cysts and Odontogenic Tumors Based on the 2022 WHO Classification." Oral Diseases, 2024–2025. https://doi.org/10.1111/odi.15146

• Vered, M. and Wright, J.M. "Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Odontogenic and Maxillofacial Bone Tumours." PMC / Turkish Journal of Pathology, 2022. https://pmc.ncbi.nlm.nih.gov/articles/PMC9999699/

• Tamiolakis, P., Thermos, G., Tosios, K.I., and Sklavounou-Andrikopoulou, A. "Demographic and Clinical Characteristics of 5294 Jaw Cysts: A Retrospective Study of 38 Years." Head and Neck Pathology, 2019. https://doi.org/10.1007/s12105-019-01011-7

• StatPearls. "Odontogenic Tumors of the Jaws." NCBI Bookshelf, National Library of Medicine, 2023. https://www.ncbi.nlm.nih.gov/books/NBK572116/

• StatPearls. "Oral Surgery, Biopsies." NCBI Bookshelf, National Library of Medicine, 2023. https://www.ncbi.nlm.nih.gov/books/NBK594246/

• Martin, L.H.C. and Speight, P.M. "Odontogenic Cysts: Classification, Histological Features and a Practical Approach to Common Diagnostic Problems." Diagnostic Histopathology, 2022. https://doi.org/10.1016/j.mpdhp.2022.01.007

• Ikeshima, A. et al. "Comparison of Computed Tomography Findings Between Odontogenic Keratocyst and Ameloblastoma in the Mandible: Criteria for Differential Diagnosis." ScienceDirect, 2022. https://doi.org/10.1016/j.oooo.2022.05.009

• Negreiros Nunes Alves, S.M. et al. "A Network Meta-Analysis Assessing the Effectiveness of Various Radical and Conservative Surgical Approaches Regarding Recurrence in Treating Solid/Multicystic Ameloblastomas." Scientific Reports, 2023. https://doi.org/10.1038/s41598-023-32190-7

• Gümgüm, S. et al. "Controversies in Ameloblastoma Management: Evaluation of Decision Making Based on a Retrospective Analysis." PMC, 2021. https://pmc.ncbi.nlm.nih.gov/articles/PMC7980285/

• Moreira, A. et al. "Contemporary Diagnostic Imaging of Oral Squamous Cell Carcinoma: A Review of Literature." PMC, 2017. https://pmc.ncbi.nlm.nih.gov/articles/PMC5391802/

• Bhatt, V. and Damera, A. "Diagnosing the Most Common Odontogenic Cystic and Osseous Lesions of the Jaws for the Practicing Pathologist." Modern Pathology, 2017. https://doi.org/10.1038/modpathol.2016.191

• World Health Organization. WHO Classification of Head and Neck Tumours, 5th Edition. International Agency for Research on Cancer, Lyon, 2022. https://tumourclassification.iarc.who.int/

Frequently asked questions

What are jaw cysts: Fluid or tissue-filled lesions that grow inside jaw bones

Are jaw cysts common: Yes, commonly encountered in oral and maxillofacial pathology

What causes jaw cysts: Epithelial remnants from tooth development that abnormally proliferate

Are jaw cysts always symptomatic: No, many grow silently for months or years

What is the most common type of jaw cyst: Radicular cysts (58.6% of cases)

What is the second most common jaw cyst: Dentigerous cysts (17.9% of cases)

What is the third most common jaw cyst: Odontogenic keratocysts (13.3% of cases)

What causes a dentigerous cyst: Fluid accumulation between an unerupted tooth crown and its dental follicle

Which tooth is most commonly associated with dentigerous cysts: Impacted wisdom teeth

Are dentigerous cysts painful: Usually they cause minimal discomfort

Can dentigerous cysts become dangerous if untreated: Yes, serious lesions can arise within their walls

Can cancer develop inside a dentigerous cyst: Yes, including mucoepidermoid carcinoma and squamous cell carcinoma

What percentage of ameloblastomas arise within a dentigerous cyst: 17%

Can an untreated dentigerous cyst cause jaw fracture: Yes, pathologic jaw fracture is a risk

What is an odontogenic keratocyst (OKC): A rare, benign but locally aggressive developmental jaw cyst

Where does OKC most commonly occur: The posterior mandible

What decade of life does OKC most commonly present: The third decade of life

Does OKC cause visible swelling: Bony expansion is uncommon with OKC

Why does OKC expand without obvious swelling: It grows via increased epithelial turnover, not osmotic pressure

What gene mutation is associated with OKC: Mutations in the PTCH gene on chromosome 9q

What percentage of OKCs show PTCH mutations: Approximately one third

What syndrome is associated with multiple OKCs: Nevoid basal cell carcinoma syndrome (Gorlin-Goltz Syndrome)

Do multiple OKCs in a child require further investigation: Yes, referral for genetic evaluation is necessary

What is ameloblastoma: The second most common odontogenic tumour after odontoma

Is ameloblastoma malignant: No, it is classified as benign

Is ameloblastoma harmless despite being benign: No, it is locally aggressive with high recurrence rates

What are symptoms of ameloblastoma: Slow-growing swelling, cortical bone bulging, and malocclusion

Can ameloblastoma cause facial deformity: Yes, potentially significant facial deformity

What is the most common odontogenic tumour: Odontoma (40.1% of odontogenic tumours)

What percentage of biopsy requests are jaw cysts: 18.4%

What percentage of biopsy requests are odontogenic tumours: 2.4%

What is the first imaging tool used for jaw lesions: Panoramic radiography (OPG)

Can an OPG definitively diagnose a jaw lesion type: No, it cannot reliably distinguish between cyst types

Can a dentigerous cyst and OKC look identical on OPG: Yes, they can appear radiographically identical

What imaging provides 3D assessment of jaw lesions: Cone-beam computed tomography (CBCT)

What is the sensitivity of CBCT for detecting osteolysis: 89–93%

What is the specificity of CBCT for detecting osteolysis: 60–96.5%

What is the limitation of CBCT: Poor assessment of soft tissues

What imaging is used when soft tissue assessment is needed: MRI

What is the sensitivity of CT for detecting mandibular invasion by squamous cell carcinoma: 96%

What is the specificity of CT for detecting mandibular invasion: 87%

Can imaging alone definitively diagnose a jaw lesion: No, histopathology is required for definitive diagnosis

What is the only way to definitively diagnose a jaw lesion: Histopathological examination (biopsy)

What type of biopsy is recommended when malignancy is suspected: Incisional biopsy

Why is excisional biopsy problematic for suspected oral cancer: Oncologists cannot determine the original lesion location

What is the standard treatment for most jaw cysts: Simple enucleation

What adjunct treatments reduce OKC recurrence after enucleation: Carnoy's solution or peripheral ostectomy

What is marsupialization: Creating a surgical window to allow a cyst to drain and shrink

When is marsupialization used: For very large cysts near vital structures or at fracture risk

What is the recurrence rate of ameloblastoma after radical treatment: 15–25%

What is the recurrence rate of ameloblastoma after conservative treatment: 55–90%

Which surgical approach ranks highest for reducing ameloblastoma recurrence: Segmental resection

What is the recommended surgical margin for solid/multicystic ameloblastoma: 1 cm margins

How long after treatment can ameloblastoma recur: Up to 10–15 years after treatment

Is long-term follow-up required after ameloblastoma treatment: Yes, long-term radiographic surveillance is non-negotiable

What is the gold standard for mandibular reconstruction after resection: Free fibula flap

Can dental implants be placed after jaw reconstruction: Yes, into the reconstructed bone

What is the most common cancer of the oral cavity: Oral squamous cell carcinoma (OSCC)

What percentage of oral cavity cancers does squamous cell carcinoma represent: 95%

Can malignant jaw lesions mimic benign cysts on imaging: Yes, exceptionally rarely

What is a red flag symptom for jaw malignancy: A non-healing ulcer persisting beyond three weeks

What does new-onset lip or chin numbness suggest: Possible inferior alveolar nerve involvement

What does an irregular or poorly defined jaw radiolucency suggest: Possible malignancy requiring urgent review

Is early oral squamous cell carcinoma commonly detected: No, most cases are diagnosed in late stages

Who should diagnose and manage jaw lesions: A board-registered oral and maxillofacial surgeon

Can a general dentist manage jaw cysts and tumours: No, specialist expertise is required

What determines whether enucleation or resection is needed: Histopathological diagnosis

Does treatment choice differ between a dentigerous cyst and ameloblastoma: Yes, dramatically different treatments are required

Where is Smile Solutions located: Level 12 and Tower, 220 Collins Street, Melbourne CBD

How many clinicians does Smile Solutions have: 60+ clinicians

How many board-registered specialists does Smile Solutions have: 25+ specialists

How many patients has Smile Solutions treated: Over 250,000 patients

How long has Smile Solutions been operating: Since 1993

Is a referral required to see a Smile Solutions oral surgeon: No referral is required

What is the Smile Solutions contact number: 13 13 96

Label facts summary

Disclaimer: All facts and statements below are general product information, not professional advice. Consult relevant experts for specific guidance.

Verified label facts

No product specification data was provided. No Product Facts table was present in the submitted content. Accordingly, no label-verifiable facts (ingredients, certifications, dimensions, weight, GTIN/MPN, or technical specifications) can be extracted or listed.

Practice-identifiable data points (sourced from practice listing information within the content):

• Practice name: Smile Solutions
• Address: Level 12 and Tower, 220 Collins Street, Melbourne CBD
• Building: Manchester Unity Building
• Operating since: 1993
• Clinician count: 60+ clinicians
• Board-registered specialists: 25+ specialists
• Patients treated: Over 250,000
• Contact number: 13 13 96
• Website: smilesolutions.com.au
• Referral requirement: No referral required

General practice claims

• Smile Solutions provides world-class oral and maxillofacial surgery care
• Smile Solutions operates within a truly multidisciplinary environment
• The practice enables the full diagnostic and surgical pathway to be coordinated under one roof
• The practice offers greater continuity of care, clearer communication, and a more personalised treatment experience
• The oral and maxillofacial surgery team manages jaw pathology every day as a core part of specialist care
• The team guides patients through every stage with clinical excellence and a genuinely caring approach